Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig02801 |
poly binding cytoplasmic 1 |
882 |
20 |
3.23E-125 |
65.35% |
7 |
P:chordate embryonic development; F:protein self-association; F:poly(A) RNA binding; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:mRNA stabilization; C:cytoplasm; F:eukaryotic initiation factor 4G binding |
|
|
contig02802 |
---NA--- |
378 |
0 |
|
|
0 |
|
|
|
contig02803 |
---NA--- |
516 |
0 |
|
|
0 |
|
|
|
contig02804 |
---NA--- |
1154 |
0 |
|
|
0 |
|
|
|
contig02805 |
---NA--- |
346 |
0 |
|
|
0 |
|
|
|
contig02806 |
family with sequence similarity member a |
838 |
20 |
1.94E-84 |
78.60% |
3 |
F:F; P:P; C:C |
|
|
contig02807 |
solute carrier family member 3 |
692 |
7 |
3.50E-08 |
82.43% |
2 |
P:sodium ion transport; C:membrane |
|
|
contig02808 |
kinesin family member 11 |
354 |
20 |
2.12E-12 |
79.15% |
12 |
C:cytoplasm; P:mitotic spindle organization; P:microtubule-based movement; P:spindle pole body organization; P:mitosis; F:ATP binding; C:spindle pole; C:spindle microtubule; C:kinesin complex; P:mitotic centrosome separation; P:cell division; F:microtubule motor activity |
|
|
contig02809 |
immature colon carcinoma transcript 1 |
278 |
20 |
2.39E-16 |
74.70% |
5 |
F:translation release factor activity; F:F; P:P; P:translational termination; C:C |
|
|
contig02810 |
ndrg family member 3 |
1464 |
20 |
4.72E-166 |
88.00% |
5 |
F:phosphopantetheine binding; P:negative regulation of cell growth; C:cytoplasm; P:cell differentiation; P:spermatogenesis |
|
|
contig02811 |
---NA--- |
164 |
0 |
|
|
0 |
|
|
|
contig02812 |
unnamed protein product [Tetraodon nigroviridis] |
247 |
1 |
2.93E-06 |
65.00% |
0 |
|
|
|
contig02813 |
g protein pathway suppressor 1 |
1724 |
20 |
0 |
95.30% |
7 |
C:cytoplasm; F:protein binding; P:JNK cascade; P:inactivation of MAPK activity; P:cell cycle; F:GTPase inhibitor activity; C:signalosome |
|
|
contig02814 |
nuclear factor of activated t- calcineurin-dependent 2 interacting protein |
510 |
20 |
8.42E-18 |
62.35% |
4 |
F:protein binding; P:cytokine production; P:regulation of transcription, DNA-dependent; C:intracellular part |
|
|
contig02815 |
unnamed protein product [Tetraodon nigroviridis] |
253 |
1 |
1.22E-07 |
82.00% |
0 |
|
|
|
contig02816 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig02817 |
---NA--- |
395 |
0 |
|
|
0 |
|
|
|
contig02818 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
contig02819 |
---NA--- |
382 |
0 |
|
|
0 |
|
|
|
contig02820 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
contig02821 |
---NA--- |
370 |
0 |
|
|
0 |
|
|
|
contig02822 |
---NA--- |
437 |
0 |
|
|
0 |
|
|
|
contig02823 |
lyrm7 homolog |
684 |
20 |
1.48E-19 |
76.15% |
2 |
F:F; C:C |
|
|
contig02824 |
---NA--- |
422 |
0 |
|
|
0 |
|
|
|
contig02825 |
nuclear cap binding protein subunit 80kda |
393 |
20 |
4.19E-16 |
88.70% |
6 |
F:RNA binding; F:protein binding; P:positive regulation of mRNA 3'-end processing; P:mRNA transport; C:nucleus; P:mRNA cleavage |
|
|
contig02826 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig02827 |
---NA--- |
521 |
0 |
|
|
0 |
|
|
|
contig02828 |
---NA--- |
501 |
0 |
|
|
0 |
|
|
|
contig02829 |
---NA--- |
690 |
0 |
|
|
0 |
|
|
|
contig02830 |
---NA--- |
324 |
0 |
|
|
0 |
|
|
|
contig02831 |
mitochondrial ribosomal protein s16 |
856 |
20 |
3.59E-65 |
83.20% |
3 |
C:mitochondrial small ribosomal subunit; F:structural constituent of ribosome; P:translation |
EC:3.6.5.3 |
|
contig02832 |
eukaryotic translation initiation factor 3 subunit k |
292 |
20 |
1.48E-13 |
96.30% |
7 |
C:eukaryotic translation initiation factor 3 complex; F:RNA binding; F:protein binding; P:regulation of translational initiation; F:translation initiation factor activity; C:nucleus; F:ribosome binding |
|
|
contig02833 |
---NA--- |
319 |
0 |
|
|
0 |
|
|
|
contig02834 |
---NA--- |
353 |
0 |
|
|
0 |
|
|
|
contig02835 |
translocator protein |
373 |
20 |
3.89E-22 |
89.90% |
2 |
F:receptor activity; C:integral to membrane |
|
|
contig02836 |
---NA--- |
891 |
0 |
|
|
0 |
|
|
|
contig02837 |
cg3552- isoform a |
348 |
20 |
5.40E-32 |
69.45% |
3 |
F:F; F:phosphopantetheine binding; C:C |
|
|
contig02838 |
---NA--- |
445 |
0 |
|
|
0 |
|
|
|
contig02839 |
---NA--- |
630 |
0 |
|
|
0 |
|
|
|
contig02840 |
---NA--- |
271 |
0 |
|
|
0 |
|
|
|
contig02841 |
---NA--- |
216 |
0 |
|
|
0 |
|
|
|
contig02842 |
phosphoribosylformylglycinamidine synthase |
418 |
20 |
2.15E-12 |
63.05% |
10 |
P:'de novo' IMP biosynthetic process; F:ligase activity; F:phosphoribosylformylglycinamidine synthase activity; F:nucleotide binding; C:cytoplasm; F:ATP binding; F:catalytic activity; P:glutamine metabolic process; F:protein binding; P:purine nucleotide biosynthetic process |
|
|
contig02843 |
muts homolog 6 |
631 |
20 |
8.06E-96 |
85.20% |
24 |
F:oxidized purine DNA binding; P:negative regulation of DNA recombination; F:dinucleotide insertion or deletion binding; F:MutLalpha complex binding; F:purine-specific mismatch base pair DNA N-glycosylase activity; F:four-way junction DNA binding; F:ADP binding; P:DNA damage response, signal transduction resulting in induction of apoptosis; F:single guanine insertion binding; P:response to UV; P:determination of adult lifespan; F:single thymine insertion binding; P:somatic hypermutation of immunoglobulin genes; P:base-excision repair; F:magnesium ion binding; C:nuclear chromatin; F:ATPase activity; F:protein homodimerization activity; F:chromatin binding; F:guanine/thymine mispair binding; P:mismatch repair; F:ATP binding; C:MutSalpha complex; P:isotype switching |
|
|
contig02844 |
---NA--- |
329 |
0 |
|
|
0 |
|
|
|
contig02845 |
coiled-coil domain containing 130 |
752 |
20 |
3.72E-110 |
88.35% |
2 |
F:protein binding; P:response to virus |
|
|
contig02846 |
---NA--- |
522 |
0 |
|
|
0 |
|
|
|
contig02847 |
2 -phosphodiesterase |
275 |
20 |
4.83E-25 |
73.60% |
2 |
F:F; C:C |
|
|
contig02848 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
contig02849 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig02850 |
unnamed protein product [Tetraodon nigroviridis] |
479 |
1 |
2.10E-04 |
65.00% |
0 |
|
|
|
contig02851 |
ring finger protein 25 |
468 |
15 |
4.00E-19 |
65.53% |
3 |
F:protein binding; F:metal ion binding; P:zinc ion transport |
|
|
contig02852 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig02853 |
---NA--- |
324 |
0 |
|
|
0 |
|
|
|
contig02854 |
mediator of rna polymerase ii subunit 8 homolog |
801 |
20 |
1.89E-110 |
84.85% |
4 |
; P:transcription antitermination; P:ubiquitin cycle; P:regulation of transcription, DNA-dependent |
|
|
contig02855 |
transmembrane and coiled-coil domains 6 |
666 |
20 |
4.59E-47 |
61.90% |
5 |
F:binding; C:integral to membrane; C:membrane; P:P; C:C |
|
|
contig02856 |
hydroxyacyl-coenzyme a dehydrogenase 3-ketoacyl-coenzyme a thiolase enoyl-coenzyme a hydratase (trifunctional protein) alpha subunit |
403 |
20 |
4.10E-48 |
94.75% |
11 |
F:NAD or NADH binding; F:long-chain-enoyl-CoA hydratase activity; F:acetyl-CoA C-acyltransferase activity; C:mitochondrial inner membrane; C:fatty acid beta-oxidation multienzyme complex; P:response to bacterium; F:3-hydroxyacyl-CoA dehydrogenase activity; P:fatty acid beta-oxidation; P:response to drug; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:enoyl-CoA hydratase activity |
EC:4.2.1.74; EC:2.3.1.16; EC:1.1.1.35; EC:1.1.1.211; EC:4.2.1.17 |
|
contig02857 |
isoform cra_b |
878 |
20 |
7.53E-42 |
57.50% |
6 |
F:nucleic acid binding; F:metal ion binding; F:zinc ion binding; P:P; C:nucleus; C:intracellular |
|
|
contig02858 |
malignant t cell amplified sequence 1 |
930 |
20 |
6.75E-100 |
96.75% |
2 |
P:positive regulation of cell proliferation; F:RNA binding |
|
|
contig02859 |
src homology 2 domain-containing transforming protein partial |
259 |
3 |
2.29E-14 |
86.00% |
0 |
|
|
|
contig02860 |
inhibitor of growth member 2 |
1589 |
20 |
7.18E-115 |
76.45% |
12 |
P:chromatin modification; F:zinc ion binding; P:regulation of transcription, DNA-dependent; P:regulation of cell growth; F:DNA binding; C:CCAAT-binding factor complex; F:transcription activator activity; F:protein binding; P:signal transduction; C:chromosome; F:chromatin binding; P:positive regulation of transcription |
|
|
contig02861 |
eh-domain containing 1 |
427 |
20 |
5.99E-60 |
90.70% |
10 |
F:GTP binding; C:plasma membrane; C:endocytic vesicle; F:protein binding; C:early endosome membrane; F:calcium ion binding; F:ATP binding; P:endosome transport; P:endocytosis; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig02862 |
ankyrin repeat domain 43 |
530 |
20 |
1.29E-59 |
72.05% |
0 |
|
|
|
contig02863 |
fukutin |
266 |
20 |
1.69E-09 |
88.90% |
6 |
C:Golgi membrane; C:extracellular space; P:muscle organ development; P:nervous system development; F:transferase activity; C:integral to membrane |
|
|
contig02864 |
di-n-acetyl- |
660 |
20 |
1.59E-68 |
82.10% |
5 |
F:chitinase activity; C:extracellular space; P:chitin catabolic process; F:cation binding; C:lysosome |
EC:3.2.1.14 |
|
contig02865 |
---NA--- |
175 |
0 |
|
|
0 |
|
|
|
contig02866 |
nipsnap homolog 3a |
268 |
20 |
3.49E-23 |
73.25% |
3 |
C:cytoplasm; P:P; C:C |
|
|
contig02867 |
tripartite motif-containing 32 |
387 |
1 |
1.04E-19 |
77.00% |
3 |
P:intracellular transport; P:pigment granule aggregation in cell center; F:binding |
|
|
contig02868 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig02869 |
---NA--- |
366 |
0 |
|
|
0 |
|
|
|
contig02870 |
subfamily member 28 |
335 |
20 |
2.90E-46 |
73.45% |
1 |
F:protein binding |
|
|
contig02871 |
histone deacetylase 2 |
1291 |
20 |
1.92E-27 |
89.45% |
17 |
P:neuron migration; P:Wnt receptor signaling pathway; F:histone deacetylase activity; P:regulation of transcription, DNA-dependent; P:histone deacetylation; P:positive regulation of neurogenesis; C:histone deacetylase complex; P:oligodendrocyte differentiation; F:enzyme binding; P:negative regulation of cell proliferation; F:transcription factor activity; C:heterochromatin; C:replication fork; P:facial nucleus development; F:transcription factor binding; C:cytoplasm; P:convergent extension involved in axis elongation |
|
|
contig02872 |
class member 1 |
254 |
20 |
9.04E-19 |
83.15% |
8 |
C:soluble fraction; F:alpha-mannosidase activity; C:lysosome; P:mannose metabolic process; P:learning or memory; P:protein deglycosylation; F:zinc ion binding; F:mannose binding |
EC:3.2.1.24 |
|
contig02873 |
protein kinase c binding protein 1 |
320 |
20 |
2.61E-18 |
81.60% |
2 |
F:zinc ion binding; F:protein binding |
|
|
contig02874 |
---NA--- |
175 |
0 |
|
|
0 |
|
|
|
contig02875 |
---NA--- |
106 |
0 |
|
|
0 |
|
|
|
contig02876 |
gtp-binding protein sar1a |
325 |
20 |
1.85E-24 |
98.00% |
7 |
C:endoplasmic reticulum membrane; F:GTP binding; C:Golgi apparatus; P:vesicle-mediated transport; F:magnesium ion binding; P:intracellular protein transport; P:small GTPase mediated signal transduction |
|
|
contig02877 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
contig02878 |
canopy 4 homolog |
613 |
20 |
9.15E-78 |
87.85% |
4 |
P:negative regulation of signal transduction; C:extracellular region; P:regulation of protein localization; F:receptor binding |
|
|
contig02879 |
---NA--- |
187 |
0 |
|
|
0 |
|
|
|
contig02880 |
eukaryotic translation initiation factor 4b |
1214 |
20 |
2.31E-19 |
72.05% |
2 |
F:nucleic acid binding; F:nucleotide binding |
|
|
contig02881 |
minichromosome maintenance complex component 5 |
441 |
20 |
2.05E-55 |
88.20% |
12 |
P:mitotic cell cycle; P:regulation of DNA replication initiation; P:regulation of transcription, DNA-dependent; P:DNA unwinding involved in replication; C:MCM complex; F:DNA binding; F:ATP binding; C:chromatin; F:protein binding; F:DNA-dependent ATPase activity; P:negative regulation of apoptosis; F:chromatin binding |
|
|
contig02882 |
---NA--- |
351 |
0 |
|
|
0 |
|
|
|
contig02883 |
shwachman-bodian-diamond syndrome |
521 |
20 |
1.25E-35 |
93.55% |
1 |
P:inner cell mass cell proliferation |
|
|
contig02884 |
---NA--- |
706 |
0 |
|
|
0 |
|
|
|
contig02885 |
cathepsin d |
480 |
20 |
1.65E-17 |
93.25% |
7 |
C:lysosome; C:signal recognition particle, endoplasmic reticulum targeting; P:proteolysis; F:pepsin A activity; F:endopeptidase inhibitor activity; P:negative regulation of signal transduction; F:cathepsin D activity |
EC:3.6.5.4; EC:3.4.23.1; EC:3.4.23.5 |
|
contig02886 |
rcd1 required for cell differentiation1 homolog |
567 |
20 |
8.56E-21 |
95.65% |
3 |
P:cytokine-mediated signaling pathway; P:sex differentiation; F:binding |
|
|
contig02887 |
myb binding protein 1a |
535 |
5 |
1.07E-16 |
60.60% |
1 |
P:primary metabolic process |
|
|
contig02888 |
integrator complex subunit 7 |
600 |
20 |
1.12E-72 |
91.30% |
4 |
F:protein binding; P:protein targeting; P:snRNA processing; C:integrator complex |
|
|
contig02889 |
---NA--- |
551 |
0 |
|
|
0 |
|
|
|
contig02890 |
---NA--- |
337 |
0 |
|
|
0 |
|
|
|
contig02891 |
dna-directed dna polymerase epsilon 2 |
564 |
20 |
2.56E-94 |
95.40% |
5 |
F:DNA-directed DNA polymerase activity; P:DNA replication; F:DNA binding; C:nucleus; P:DNA repair |
EC:2.7.7.7 |
|
contig02892 |
bola-like 1 ( coli) isoform cra_a |
1044 |
20 |
1.26E-68 |
77.95% |
1 |
F:protein binding |
|
|
contig02893 |
mitochondrial ribosomal protein s2 |
1059 |
20 |
4.82E-116 |
83.80% |
4 |
F:structural constituent of ribosome; C:small ribosomal subunit; P:translation; C:mitochondrion |
EC:3.6.5.3 |
|
contig02894 |
transcription elongation factor b polypeptide 3 binding protein 1 |
814 |
20 |
1.32E-74 |
79.30% |
5 |
C:chromatin; F:exonuclease activity; F:DNA binding; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
contig02895 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig02896 |
---NA--- |
1048 |
0 |
|
|
0 |
|
|
|
contig02897 |
---NA--- |
346 |
0 |
|
|
0 |
|
|
|
contig02898 |
pseudouridylate synthase 1 |
900 |
20 |
2.84E-124 |
76.60% |
8 |
; F:pseudouridylate synthase activity; C:nucleolus; P:positive regulation of transcription from RNA polymerase II promoter; F:ligand-dependent nuclear receptor transcription coactivator activity; C:transcription factor complex; P:tRNA pseudouridine synthesis; F:DNA binding |
EC:4.2.1.70 |
|
contig02899 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
contig02900 |
---NA--- |
298 |
0 |
|
|
0 |
|
|
|
100 Rows returned.